Current Clinical Trials
There is currently no way to stop the progression of Alzheimer’s disease. Clinical trials are necessary in order to find new treatments. Our center is involved in a number of research studies for people with mild cognitive impairment (MCI) as well as mild to moderate Alzheimer’s disease. We also have prevention studies for older individuals who have no memory loss. We have some trials which are only observational, evaluating changes in memory over time in participants, as well as trials investigating new treatments. These treatments may involve pills, while others use injections or infusions in a vein. Some of our studies involve brain imaging techniques such as PET scans to detect proteins in the brain associated with memory loss and Alzheimer’s disease.
Currently Enrolling Clinical Trials for Patients with Memory Loss
- A 96-week trial investigating an infusion-based treatment which may target tau protein in the brain. This study is for patients with mild cognitive impairment and mild Alzheimer’s disease.
- A 4-year observational study involving neurocognitive testing and imaging, which may help to learn more about Alzheimer’s disease. This study is for patients 55-90 years old with mild cognitive impairment or mild Alzheimer’s disease.
Currently Enrolling Clinical Trials for Patients without Memory Loss
- Two different prevention studies for individuals 60-75 years old who are concerned about developing Alzheimer’s due to their genotype but who currently have no memory problems.
We always have new trials just around the corner. Please check back with us for updates!
For more information about our programs, contact
Kelly Rodrigo at (813) 974-4904 or email@example.com